Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.

NCT00056459 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1168

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms
Colonic Neoplasms
Rectal Neoplasms

Interventions

DRUG: Vatalanib

Sponsor

Novartis

Collaborators

[object Object]